Why Are Enraged Parents Filing Risperdal Lawsuit Claims On Behalf Of Their Sons?
Written by Stephen Fields on April 21, 2015
Approximately 1 year ago, Johnson & Johnson settled charges of illegal marketing of its antipsychotic Risperdal. The charges arose from an investigation launched by the U.S. Department of Justice. The drug maker agreed to pay $2.2 billion to end the investigation. But that wasn’t the end of J&J’s legal troubles involving the antipsychotic. It’s currently facing hundreds of Risperdal gynecomastia lawsuit claims filed by angered parents.
Gynecomastia refers to abnormal breast enlargement in men and young boys. The condition has been observed in numerous cases involving adolescent males after taking Risperdal to help control schizophrenia and other mental disorders. Parents are understandably furious that Johnson & Johnson, the manufacturer, neglected to warn them about the possible risk of Risperdal Gynecomastia.
Breast development in young boys can be a traumatic experience. It can destroy the victim’s self-esteem and severely impair his ability to interact with his peers. Many adolescents who developed breasts after taking J&J’s antipsychotic have undergone mastectomies to have them surgically removed.
Call 1-888-210-9968 today if you or your son experienced this problem after using Risperdal. You can hold the manufacturer accountable for its failure to disclose the risk, and pursue fair compensation for your family.
J&J Failed To Warn About Risperdal Breast Enlargement
Risperdal was originally created by Janssen Pharmaceuticals, now a subsidiary of Johnson & Johnson. It was approved by the FDA in 1994.
Studies have shown that use of the medication may cause elevated levels of prolactin, a hormone secreted by the pituitary gland. Researchers have long known that increased secretion of prolactin is associated with breast growth. Unfortunately, that outcome appears to be occurring in adolescent boys taking Risperdal.
The controversy over J&J’s role in promoting Risperdal focuses on the company’s failure to warn the public that the drug might trigger the onset of gynecomastia. Claimants allege the manufacturer knew or should have known about the danger.
Studies have demonstrated since 2004 that use of Risperdal may be connected to elevated prolactin levels in adolescent males’ blood (hyperprolactinemia). Because increased secretion of prolactin is known to stimulate breast growth, claimants assert J&J should have notified them that gynecomastia was a possible side effect of therapy.
Risperdal Gynecomastia Causes Psychological Harm In Boys
Young boys coping with the alarming bodily changes that accompany gynecomastia are likely to suffer from a psychological impact. So say researchers at Boston Children’s Hospital.
In 2013, they found that abnormal breast growth can adversely affect a young boy’s self-esteem, emotional health and quality of life. The researchers found no significant difference in the severity of those problems as they related to the extent of the condition. Even boys with mild gynecomastia showed psychological and emotional adverse effects.
DOJ: Johnson & Johnson Illegally Marketed Risperdal
Johnson & Johnson has been repeatedly criticized for its aggressive promotion of Risperdal and misrepresentation of its safety. As noted earlier, the Justice Department launched a formal investigation into those matters years ago. In 2012, J&J negotiated a $2.2 billion Risperdal lawsuit settlement to end the investigation.
During the probe, the DOJ reviewed allegations that the pharmaceutical giant had illegally marketed Risperdal for off-label uses. One of those uses was the treatment of children with mental disabilities. Risperdal was eventually approved for limited use in children in 2006. But J&J allegedly promoted the drug for such purposes several years beforehand.
The Justice Department also researched accusations that Johnson & Johnson misrepresented the safety and efficacy of Risperdal and whether the company made false and misleading claims to those effects to the public and medical community.
With evidence of reckless marketing mounting, J&J chose not to wait for the DOJ to conclude its investigation. The company must have felt the $2.2 billion settlement shielded it from an even worse outcome.
Parents Seek Recompense Through Risperdal Lawsuit Claims
Many parents of young boys injured by Risperdal have filed lawsuits against Johnson & Johnson and Janssen Pharmaceuticals. They claim both companies should have alerted the public about the risk of developing gynecomastia. Had parents and victims known about the potential danger, they could have avoided the problem by choosing another antipsychotic.
If your family has been adversely affected by Risperdal and gynecomastia, call 1-888-210-9968 to learn about your legal rights. Our Risperdal breast growth lawyers are here to listen, review your case, offer advice and answer your questions regarding your legal options.
The case evaluation is completely free. Moreover, if you decide to pursue a claim against the manufacturer, you can do so on a contingency basis. You pay no legal fees unless we successfully obtain monetary compensation for you and your family.
There is limited time to file a Risperdal breast growth lawsuit claim. Contact our offices at your earliest convenience to have our attorneys aggressively protect your rights.